{"id":5263,"date":"2025-01-01T12:00:41","date_gmt":"2025-01-01T12:00:41","guid":{"rendered":"http:\/\/i-base.info\/guides\/?page_id=5263"},"modified":"2025-01-15T12:30:32","modified_gmt":"2025-01-15T12:30:32","slug":"references","status":"publish","type":"page","link":"https:\/\/i-base.info\/guides\/changing\/references","title":{"rendered":"References"},"content":{"rendered":"<p><strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright wp-image-15453\" src=\"https:\/\/i-base.info\/guides\/wp-content\/uploads\/2025\/01\/ChangingJan2025COVER.png\" alt=\"\" width=\"144\" height=\"201\" \/>Information in this guide is based on the following treatment guidelines.<\/strong><\/p>\n<p>British HIV Association (BHIVA) guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy (2022, 2023 interim update)<\/p>\n<p><strong><a href=\"https:\/\/bhiva.org\/clinical-guidelines\/\">bhiva.org\/clinical-guidelines<\/a><\/strong><\/p>\n<p>European AIDS Clinical Society (EACS) Guidelines for clinical management and treatment of HIV-infected adults in Europe. Version 10.1 (October 2020).<\/p>\n<p><strong><a href=\"https:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/\">eacsociety.org\/guidelines\/eacs-guidelines<\/a><\/strong><\/p>\n<p>US HHS Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (June 2021)<\/p>\n<p><strong><a href=\"https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv\/whats-new-guidelines\">clinicalinfo.hiv.gov\/en\/guidelines\/adult-and-adolescent-arv\/whats-new-guidelines<\/a><\/strong><\/p>\n<p><strong>Recent papers<\/strong><\/p>\n<p>Bachelard A for the ANRS CO05 VIH-2 cohort study group , Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug Resistant Hiv-2 Infection, <em>Clinical Infectious Diseases<\/em>, 2023;, ciad695, <a href=\"https:\/\/doi.org\/10.1093\/cid\/ciad695\" data-google-interstitial=\"false\">doi.org\/10.1093\/cid\/ciad695<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Information in this guide is based on the following treatment guidelines. British HIV Association (BHIVA) guidelines for the treatment of HIV-1 positive adults with antiretroviral therapy (2022, 2023 interim update) bhiva.org\/clinical-guidelines European AIDS Clinical Society (EACS) Guidelines for clinical management &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":10,"menu_order":49,"comment_status":"closed","ping_status":"closed","template":"page-guides.php","meta":{"footnotes":""},"class_list":["post-5263","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/pages\/5263","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/comments?post=5263"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/pages\/5263\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/pages\/10"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/guides\/wp-json\/wp\/v2\/media?parent=5263"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}